Neogen buys vet genomics assets from Beijing Anapure; FDA issues guidance on adverse event reporting for animal drugs;

> Neogen ($NEOG) has acquired the food safety and veterinary genomic assets of Beijing Anapure BioScientific, which is its Chinese distributor. Release

> The FDA issued a guidance document providing recommendations to help manufacturers of animal drugs create electronic messages to warn of adverse events. Release

> SmartVet, a maker of veterinary drugs and delivery devices, raised $5 million in a private offering. Release

> Distributor Patterson Companies ($PDCO) declared a 20-cent quarterly cash dividend. Release

> Putney, a developer of generic pet medications, hired startup veteran Catherine Conaty as vice president of finance and controller. Release

> The FDA issued an import alert warning cattle producers that three unapproved hormone treatments are being improperly marketed. Release

> Agricultural firm HJ Baker has expanded its animal health and nutrition division with 6 new hires. Release

> Kane Biotech, which is developing biofilms for veterinary drug delivery, raised nearly $1.2 million in a private offering. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…